The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting.

Abstract:

:NIH sponsored a meeting of medical and veterinary pathologists with mammary gland expertise in Annapolis in March 1999. Rapid development of mouse mammary models has accentuated the need for definitions of the mammary lesions in genetically engineered mice (GEM) and to assess their usefulness as models of human breast disease. The panel of nine pathologists independently reviewed material representing over 90% of the published systems. The GEM tumors were found to have: (1) phenotypes similar to those of non-GEM; (2) signature phenotypes specific to the transgene; and (3) some morphological similarities to the human disease. The current mouse mammary and human breast tumor classifications describe the majority of GEM lesions but unique morphologic lesions are found in many GEM. Since little information is available on the natural history of GEM lesions, a simple morphologic nomenclature is proposed that allows direct comparisons between models. Future progress requires rigorous application of guidelines covering pathologic examination of the mammary gland and the whole animal. Since the phenotype of the lesions is an essential component of their molecular pathology, funding agencies should adopt policies ensuring careful morphological evaluation of any funded research involving animal models. A pathologist should be part of each research team.

journal_name

Oncogene

journal_title

Oncogene

authors

Cardiff RD,Anver MR,Gusterson BA,Hennighausen L,Jensen RA,Merino MJ,Rehm S,Russo J,Tavassoli FA,Wakefield LM,Ward JM,Green JE

doi

10.1038/sj.onc.1203277

subject

Has Abstract

pub_date

2000-02-21 00:00:00

pages

968-88

issue

8

eissn

0950-9232

issn

1476-5594

journal_volume

19

pub_type

共识发展会议,杂志文章,评审

相关文献

ONCOGENE文献大全
  • PAUF functions in the metastasis of human pancreatic cancer cells and upregulates CXCR4 expression.

    abstract::Pancreatic cancer is characterized by early metastatic spread, but the process of tumor cell dissemination is largely unknown. In this study we show that the soluble protein pancreatic adenocarcinoma upregulated factor (PAUF) has an important role in the metastasis and progression of the disease. Variations in the lev...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.298

    authors: Lee Y,Kim SJ,Park HD,Park EH,Huang SM,Jeon SB,Kim JM,Lim DS,Koh SS

    更新日期:2010-01-07 00:00:00

  • The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation.

    abstract::The cbl oncogene was first identified as part of a transforming retrovirus which arose in a mouse pre-B cell lymphoma. Its protein product, p120cbl, is cytoplasmic and has several distinctive domains including a highly basic region, a RING finger motif and a large proline-rich domain. A mutation to cbl in the 70Z/3 pr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Bowtell DD,Langdon WY

    更新日期:1995-10-19 00:00:00

  • MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.

    abstract::The identification of target mRNAs is a key step for assessing the role of aberrantly expressed microRNAs in human cancer. MiR-221 is upregulated in human hepatocellular carcinoma (HCC) as well as in other malignancies. One proven target of miR-221 is CDKN1B/p27, whose downregulation affects HCC prognosis. Here, we pr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.178

    authors: Fornari F,Gramantieri L,Ferracin M,Veronese A,Sabbioni S,Calin GA,Grazi GL,Giovannini C,Croce CM,Bolondi L,Negrini M

    更新日期:2008-09-25 00:00:00

  • Potent inhibitors of cyclin-dependent kinase 2 induce nuclear accumulation of wild-type p53 and nucleolar fragmentation in human untransformed and tumor-derived cells.

    abstract::The cdk2 gene has been identified as a human cdc2/CDC28-related gene that encodes a protein kinase essential for the G1/S transition in mammalian cells, but not for the G2/M transition, which requires Cdk1, another p34cdc2/CDC28 homolog. Novel potential functions of Cdk2 have been uncovered by using two potent and spe...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203103

    authors: David-Pfeuty T

    更新日期:1999-12-09 00:00:00

  • Mechanistic insight into taxol-induced cell death.

    abstract::We analysed the involvement of proteases during taxol-mediated cell death of human A549 non-small-cell lung carcinoma cells using a proteomics approach that specifically targets protein N termini and further detects newly formed N termini that are the result of protein processing. Our analysis revealed 27 protease-med...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.96

    authors: Impens F,Van Damme P,Demol H,Van Damme J,Vandekerckhove J,Gevaert K

    更新日期:2008-07-31 00:00:00

  • Genome-wide single-nucleotide polymorphism analysis in juvenile myelomonocytic leukemia identifies uniparental disomy surrounding the NF1 locus in cases associated with neurofibromatosis but not in cases with mutant RAS or PTPN11.

    abstract::Juvenile myelomonocytic leukemia (JMML) is a malignant hematopoietic disorder whose proliferative component is a result of RAS pathway deregulation caused by somatic mutation in the RAS or PTPN11 oncogenes or in patients with underlying neurofibromatosis type 1 (NF-1), by loss of NF1 gene function. To search for poten...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210361

    authors: Flotho C,Steinemann D,Mullighan CG,Neale G,Mayer K,Kratz CP,Schlegelberger B,Downing JR,Niemeyer CM

    更新日期:2007-08-23 00:00:00

  • Expression of the antimicrobial peptide cathelicidin in myeloid cells is required for lung tumor growth.

    abstract::Antimicrobial peptides, such as the cathelicidin LL-37/hCAP-18 and its mouse homolog cathelicidin-related antimicrobial peptide (CRAMP), are important effectors of the innate immune system with direct anti-bacterial activity. Cathelicidin is possibly involved in the regulation of tumor cell growth. The aim of this stu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.248

    authors: Li D,Beisswenger C,Herr C,Schmid RM,Gallo RL,Han G,Zakharkina T,Bals R

    更新日期:2014-05-22 00:00:00

  • GRIM-19 inhibits v-Src-induced cell motility by interfering with cytoskeletal restructuring.

    abstract::GRIM-19 (Gene associated with Retinoid-Interferon-induced Mortality 19) is a novel tumor suppressor regulated by interferon/retinoid combination. We have recently shown that GRIM-19 inhibits v-Src-induced oncogenic transformation and metastatic behavior of cells. Oncogenic v-Src induces cell motility by cytoskeletal r...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.480

    authors: Sun P,Nallar SC,Kalakonda S,Lindner DJ,Martin SS,Kalvakolanu DV

    更新日期:2009-03-12 00:00:00

  • Correction: ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-β-catenin signaling.

    abstract::In the published version of this paper the author Shu-Pin Huang's surname was incorrectly given as Hwang instead of Huang. This has now been corrected in the HTML and PDF versions of the paper. ...

    journal_title:Oncogene

    pub_type: 杂志文章,已发布勘误

    doi:10.1038/s41388-018-0561-0

    authors: Pai VC,Hsu CC,Chan TS,Liao WY,Chuu CP,Chen WY,Li CR,Lin CY,Huang SP,Chen LT,Tsai KK

    更新日期:2019-02-01 00:00:00

  • FOXA1 inhibits prostate cancer neuroendocrine differentiation.

    abstract::Neuroendocrine prostate cancer (NEPC) has increasingly become a clinical challenge. The mechanisms by which neuroendocrine (NE) cells arises from prostate adenocarcinoma cells are poorly understood. FOXA1 is a transcription factor of the forkhead family that is required for prostate epithelial differentiation. In this...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.50

    authors: Kim J,Jin H,Zhao JC,Yang YA,Li Y,Yang X,Dong X,Yu J

    更新日期:2017-07-13 00:00:00

  • Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells.

    abstract::Approximately 80% of breast cancers express the estrogen receptor-alpha (ERalpha) and are treated with anti-estrogens. Resistance to these agents is a major cause of mortality. We have shown that estrogen inhibits Notch, whereas anti-estrogens or estrogen withdrawal activate Notch signaling. Combined inhibition of Not...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.323

    authors: Hao L,Rizzo P,Osipo C,Pannuti A,Wyatt D,Cheung LW,Sonenshein G,Osborne BA,Miele L

    更新日期:2010-01-14 00:00:00

  • Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy.

    abstract::The human T-cell leukemia virus type 1 (HTLV-1) was the first retrovirus discovered to be causative of a human cancer, adult T-cell leukemia. The transforming entity of HTLV-1 has been attributed to the virally-encoded oncoprotein, Tax. Unlike the v-onc proteins encoded by other oncogenic animal retroviruses that tran...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2010.537

    authors: Matsuoka M,Jeang KT

    更新日期:2011-03-24 00:00:00

  • A positive feedback loop between hepatocyte growth factor receptor and beta-catenin sustains colorectal cancer cell invasive growth.

    abstract::Overexpressed or activated hepatocyte growth factor receptor, encoded by the MET proto-oncogene, was found in the majority of colorectal carcinomas (CRCs), whose stepwise progression to malignancy requires transcriptional activation of beta-catenin. We here demonstrate that a functional crosstalk between Met and beta-...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209859

    authors: Rasola A,Fassetta M,De Bacco F,D'Alessandro L,Gramaglia D,Di Renzo MF,Comoglio PM

    更新日期:2007-02-15 00:00:00

  • Frequent homozygous deletions in lung cancer cell lines detected by a DNA marker located at 3p21.3-p22.

    abstract::Frequent allelic losses of chromosome 3p in lung cancer have been reported in a number of studies, and we previously demonstrated that 3p21.3 is one of the common regions of deletion in lung cancers and renal cell carcinomas. To further define a region containing the putative tumor suppressor gene, we performed Southe...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Yamakawa K,Takahashi T,Horio Y,Murata Y,Takahashi E,Hibi K,Yokoyama S,Ueda R,Takahashi T,Nakamura Y

    更新日期:1993-02-01 00:00:00

  • Src family kinases mediate cytoplasmic retention of activated STAT5 in BCR-ABL-positive cells.

    abstract::Persistent activation of the Abl tyrosine kinase in the BCR-ABL fusion protein is the major cause of chronic myeloid leukemia (CML). Among many other substrates BCR-ABL phosphorylates STAT5 and Src family kinases (SFK). Activated pSTAT5 is essential for initial transformation and maintenance of the disease. Cytokine-i...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.369

    authors: Chatain N,Ziegler P,Fahrenkamp D,Jost E,Moriggl R,Schmitz-Van de Leur H,Müller-Newen G

    更新日期:2013-08-01 00:00:00

  • PMP24, a gene identified by MSRF, undergoes DNA hypermethylation-associated gene silencing during cancer progression in an LNCaP model.

    abstract::Transcriptional silencing of antitumor genes via CpG island methylation could be a mechanism mediating prostate cancer (PCa) progression from an androgen-sensitive (AS) to an androgen-insensitive (AI) state. We have used the methylation-sensitive restriction fingerprinting (MSRF) technique to identify novel CpG-rich s...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207076

    authors: Wu M,Ho SM

    更新日期:2004-01-08 00:00:00

  • Protein kinase C-alpha overexpression stimulates Akt activity and suppresses apoptosis induced by interleukin 3 withdrawal.

    abstract::To investigate the role of protein kinase C (PKC) in apoptotic signaling induced by cytokine withdrawal, we expressed PKC-alpha, -delta and -epsilon individually in the 32D myeloid progenitor cells. The parental and PKC-delta- and PKC-epsilon-transfected 32D cells underwent apoptosis within 24 h in the absence of inte...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203065

    authors: Li W,Zhang J,Flechner L,Hyun T,Yam A,Franke TF,Pierce JH

    更新日期:1999-11-11 00:00:00

  • MDM2-dependent ubiquitination of nuclear and cytoplasmic P53.

    abstract::Wild-type p53 is stabilized and accumulates in the nucleus of DNA damaged cells. The effect of stabilizing p53 is to inhibit cell growth, either through a G1 cell cycle arrest or apoptotic cell death. MDM2 can inhibit p53 activity, in part, by promoting its rapid degradation through the ubiquitin proteolysis pathway. ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203980

    authors: Yu ZK,Geyer RK,Maki CG

    更新日期:2000-11-30 00:00:00

  • ALDH1L1 inhibits cell motility via dephosphorylation of cofilin by PP1 and PP2A.

    abstract::Here we report that ALDH1L1 (FDH, a folate enzyme with tumor suppressor-like properties) inhibits cell motility. The underlying mechanism involves F-actin stabilization, re-distribution of cytoplasmic actin toward strong preponderance of filamentous actin and formation of actin stress fibers. A549 cells expressing FDH...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.356

    authors: Oleinik NV,Krupenko NI,Krupenko SA

    更新日期:2010-11-25 00:00:00

  • Vital functions for lethal caspases.

    abstract::Caspases are a family of cysteine proteases expressed as inactive zymogens in virtually all animal cells. These enzymes play a central role in most cell death pathways leading to apoptosis but growing evidences implicate caspases also in nonapoptotic functions. Several of these enzymes, activated in molecular platform...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1208524

    authors: Launay S,Hermine O,Fontenay M,Kroemer G,Solary E,Garrido C

    更新日期:2005-08-04 00:00:00

  • Elimination of chronic lymphocytic leukemia cells in stromal microenvironment by targeting CPT with an antiangina drug perhexiline.

    abstract::Chronic lymphocytic leukemia (CLL) is the most common adult leukemia in the western countries and is currently incurable due, in part, to difficulty in eliminating the leukemia cells protected by stromal microenvironment. Based on previous observations that CLL cells exhibit mitochondrial dysfunction and altered lipid...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.103

    authors: Liu PP,Liu J,Jiang WQ,Carew JS,Ogasawara MA,Pelicano H,Croce CM,Estrov Z,Xu RH,Keating MJ,Huang P

    更新日期:2016-10-27 00:00:00

  • Interaction and colocalization of PGP9.5 with JAB1 and p27(Kip1).

    abstract::PGP9.5 (UCH-L1) is a member of the ubiquitin C-terminal hydrolase (UCH) family of proteins that is expressed in neuronal tissues. Our previous studies have shown that PGP9.5 was highly expressed in primary lung cancers and lung cancer cell lines. Additionally, the frequency of PGP9.5 over expression increases with tum...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205390

    authors: Caballero OL,Resto V,Patturajan M,Meerzaman D,Guo MZ,Engles J,Yochem R,Ratovitski E,Sidransky D,Jen J

    更新日期:2002-05-02 00:00:00

  • Evaluation of novel cell cycle inhibitors in mantle cell lymphoma.

    abstract::Signature abnormalities in the cell cycle and apoptotic pathway have been identified in mantle cell lymphoma (MCL), affording the opportunity to develop targeted therapies. In this study, we tested a novel class of kinase inhibitors, styryl sulfones, which differ from prior cell cycle inhibitors in that they are not r...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210350

    authors: Park IW,Reddy MV,Reddy EP,Groopman JE

    更新日期:2007-08-16 00:00:00

  • Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma.

    abstract::The programmed cell death 4 (PDCD4) gene was originally identified as a tumor-related gene in humans and acts as a tumor-suppressor in mouse epidermal carcinoma cells. However, its function and regulatory mechanisms of expression in human cancer remain to be elucidated. We therefore investigated the expression of PDCD...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209634

    authors: Zhang H,Ozaki I,Mizuta T,Hamajima H,Yasutake T,Eguchi Y,Ideguchi H,Yamamoto K,Matsuhashi S

    更新日期:2006-10-05 00:00:00

  • NF-kappaB/RelA transactivation is required for atypical protein kinase C iota-mediated cell survival.

    abstract::In chronic myelogenous leukemia (CML), the oncogene bcr-abl encodes a dysregulated tyrosine kinase that inhibits apoptosis. We showed previously that human erythroleukemia K562 cells are resistant to antineoplastic drug (taxol)-induced apoptosis through the atypical protein kinase C iota isozyme (PKC iota), a kinase d...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204607

    authors: Lu Y,Jamieson L,Brasier AR,Fields AP

    更新日期:2001-08-09 00:00:00

  • Future prospects for oncolytic therapy.

    abstract::Viruses have been engineered to replicate selectively in cancer cells, based on a number of innovative principles. Several of these viruses have entered clinical trials and have proven relatively safe, and have shown evidence of efficacy. However, further research is required to enable these agents to function systemi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209064

    authors: McCormick F

    更新日期:2005-11-21 00:00:00

  • Crosstalk between NRF2 and HIPK2 shapes cytoprotective responses.

    abstract::Homeodomain interacting protein kinase-2 (HIPK2) is a member of the HIPK family of stress-responsive kinases that modulates cell growth, apoptosis, proliferation and development. HIPK2 has several well-characterised tumour suppressor roles, but recent studies suggest it can also contribute to tumour progression, altho...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.221

    authors: Torrente L,Sanchez C,Moreno R,Chowdhry S,Cabello P,Isono K,Koseki H,Honda T,Hayes JD,Dinkova-Kostova AT,de la Vega L

    更新日期:2017-11-02 00:00:00

  • Apc and p53 interaction in DNA damage and genomic instability in hepatocytes.

    abstract::Disruption of Apc (adenomatous polyposis coli) within hepatocytes activates Wnt signalling, perturbs differentiation and ultimately leads to neoplasia. Apc negatively regulates Wnt signalling but is also involved in organizing the cytoskeleton and may have a role in chromosome segregation. In vitro studies have implic...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.342

    authors: Méniel V,Megges M,Young MA,Cole A,Sansom OJ,Clarke AR

    更新日期:2015-07-30 00:00:00

  • Cdx1 inhibits the proliferation of human colon cancer cells by reducing cyclin D1 gene expression.

    abstract::The transcription factor Cdx1 regulates intestine-specific gene expression and enterocyte differentiation. It has been hypothesized to play a role in regulating intestinal cell proliferation; however, the mechanism for this effect remains elusive. In a prior study, we demonstrated that Cdx1 expression reduced the prol...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206770

    authors: Lynch J,Keller M,Guo RJ,Yang D,Traber P

    更新日期:2003-09-25 00:00:00

  • Cell growth-regulated expression of mammalian MCM5 and MCM6 genes mediated by the transcription factor E2F.

    abstract::Initiation of DNA replication requires the function of MCM gene products, which participate in ensuring that DNA replication occurs only once in the cell cycle. Expression of all mammalian genes of the MCM family is induced by growth stimulation, unlike yeast, and the mRNA levels peak at G1/S boundary. In this study, ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202544

    authors: Ohtani K,Iwanaga R,Nakamura M,Ikeda M,Yabuta N,Tsuruga H,Nojima H

    更新日期:1999-04-08 00:00:00